Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/P1RG34 stock hub

BVMF/P1RG34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/P1RG34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.9B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/P1RG34

In the news

Latest news · BVMF/P1RG34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E5.3

P25 11.3P50 14.6P75 19.6

Trailing P/En/a

P25 15.2P50 21.5P75 27.3

ROE-52.2

P25 5.3P50 12.3P75 22.5

ROIC4.8

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/P1RG34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Ireland
Country code	BR
Employees	8,100
Employees Change	-279%
Employees Change Percent	-3.33
Enterprise value	BRL 24.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	BRL 7.9B
Price	BRL 57.5
Price currency	BRL
Rev Per Employee	2,703,564.08x
Sector	Healthcare
Sic	2834
Symbol	bvmf/P1RG34
Website	https://www.perrigo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-120.04%
EV Earnings	-2.62x
EV/EBIT	17.19x
EV/EBITDA	7.44x
EV/FCF	44.18x
EV/Sales	1.22x
FCF yield	7.11%
Forward P/E	5.34x
P/B ratio	0.61x
P/S ratio	0.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.09%
EBITDA Margin	15.25%
FCF margin	2.58%
Gross margin	34.17%
Gross Profit	BRL 7.5B
Gross Profit Growth	-9.48%
Gross Profit Growth Q	-17.03%
Gross Profit Growth3 Y	-2.81%
Gross Profit Growth5 Y	-0.58%
Net Income	BRL -9.5B
Pretax Margin	-41.04%
Profit Margin	-43.5%
Profit Per Employee	BRL -1.2M
ROA	2.09
Roa5y	2.11
ROCE	4.24
ROE	-52.23
Roe5y	-9.47
ROIC	4.85
Roic5y	2.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-58.89%
Cagr3y	-31.96%
Cagr5y	-21.74%
Div CAGR3	4.97%
Div CAGR5	5.5%
FCF Growth	-35.24%
FCF Growth3 Y	-10.11%
FCF Growth5 Y	-12.49%
OCF Growth	-36.83%
OCF Growth10 Y	-12.03%
OCF Growth3 Y	-8.54%
OCF Growth5 Y	-16.43%
Revenue Growth	-3.62x
Revenue Growth Q	-7.16x
Revenue Growth3 Y	-2.86x
Revenue Growth5 Y	0.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.47
Assets	BRL 41.8B
Cash	BRL 1.9B
Current Assets	BRL 13.3B
Current Liabilities	BRL 4.9B
Debt	BRL 20.1B
Debt EBITDA	BRL 5.59
Debt Equity	BRL 1.53
Debt FCF	BRL 35.55
Equity	BRL 13.1B
Interest Coverage	1.47
Liabilities	BRL 28.7B
Long Term Assets	BRL 28.5B
Long Term Liabilities	BRL 23.8B
Net Cash	BRL -18.2B
Net Cash By Market Cap	BRL -229
Net Debt EBITDA	BRL 5.45
Net Debt Equity	BRL 1.39
Net Debt FCF	BRL 32.23
Tangible Book Value	BRL -7.7B
Tangible Book Value Per Share	BRL -55.67
WACC	5.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.72
Inventory Turnover	2.42
Net Working Capital	BRL 7.3B
Quick ratio	1.09
Working Capital	BRL 9B
Working Capital Turnover	BRL 13.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.78%
Dividend Growth	0.11%
Dividend Growth Years	6%
Dividend per share	BRL 4.56
Dividend Years	7
Dividend Yield	7.93%
Ex Div Date	2026-02-27
Last Dividend	BRL 1.1
Payout Frequency	Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-58.86%
3Y total return	-68.51%
50-day SMA	60.13
5Y total return	-70.63%
All Time High	265.1
All Time High Change	-78.31%
All Time High Date	2020-11-03
All Time Low	49.5
All Time Low Change	16.16%
All Time Low Date	2026-03-12
ATR	1.58
Beta	0.54
Ch YTD	-25.28
High	57.5
High52	133.9
High52 Date	2025-08-25
High52ch	-57.06%
Low	57.5
Low52	49.5
Low52 Date	2026-03-20
Low52ch	16.16%
Ma50ch	-4.38%
RSI	49.5
RSI Monthly	22.69
RSI Weekly	27.65
Sharpe ratio	-1.53x
Sortino ratio	-1.93
Total Return	7.15%
Tr YTD	-24.12
Tr1m	1.95%
Tr1w	-4.26%
Tr3m	-23.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 1.6B
Operating Income Growth	-21.36
Operating Income Growth Q	-57.68
Operating Income Growth3 Y	10.11
Operating Income Growth5 Y	3.98
Operating margin	7.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	137,527,102%
Net Borrowing	-111,552,340
Shares Insiders	0.46%
Shares Institutions	105.33%
Shares Qo Q	0%
Shares Yo Y	0.78%
Short Ratio	4.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 263.6M
Average Volume	302.7x
Bv Per Share	94.83
CAPEX	BRL -428.2M
Ch1m	1.95
Ch1w	-4.26
Ch1y	-60.76
Ch3m	-24.84
Ch3y	-71.86
Ch5y	-74.44
Ch6m	-24.34
Change	-4.26%
Change From Open	0
Close	60.06
Days Gap	-4.26
Depreciation Amortization	1,675,250,780
Dollar Volume	1,322.5
Earnings Date	2026-05-06
EBIT	BRL 1.6B
EBITDA	BRL 3.3B
EPS	BRL -68.66
F Score	5
FCF	BRL 564.5M
FCF EV Yield	2.26x
Financing CF	-1,069,157,880
Fiscal Year End	December
Founded	1,887
Goodwill	8,362,985,560
Income Tax	BRL 406.2M
Investing CF	-325,464,237
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-28
Ma150	130.2
Ma150ch	-55.84%
Ma20	56.31
Ma20ch	2.12%
Net CF	-276,199,119
Open	57.5
P FCF Ratio	14.06
P OCF Ratio	7.99
Payment Date	2026-03-30
Ppne	5,162,858,520
Price Date	2026-05-08
Price EBITDA	BRL 2.38
Relative Volume	0.06x
Revenue	21,898,869,048x
SBC By Revenue	1.37x
Share Based Comp	300,831,678
Tax By Revenue	1.85x
Tr6m	-21.97%
Volume	23
Z Score	0.49

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/P1RG34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.9%

$4.56 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.5%

6 consecutive years of growth

Total shareholder yield

+7.2%

Next ex-dividend date: 2026-02-27

Performance

BVMF/P1RG34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/P1RG34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+105.3%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/P1RG34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.5

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

-1.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/P1RG34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/P1RG34 stock rating?

bvmf/P1RG34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/P1RG34 analysis?

The full report lives at /stocks/bvmf/P1RG34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/P1RG34?

The latest report frames bvmf/P1RG34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/P1RG34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.